How to Get Provigil (Modafinil) in Maine: Telehealth, Prescribers, and Pharmacy Access

Modafinil (brand name Provigil, also sold generically) is an oral wakefulness-promoting medication and a federal Schedule IV controlled substance. The FDA approved it for narcolepsy, and later for obstructive sleep apnea (OSA) residual sleepiness and shift-work disorder (SWD). In Maine, a prescription can come from a physician, a nurse practitioner, or a physician assistant licensed in the state, and the state's telehealth framework permits controlled-substance prescribing by video visit in appropriate cases. What is genuinely uncertain, and what this page cannot responsibly state without verification, is the exact prior-authorization timeline, cash price, and pharmacy stocking pattern on any given day, because those details change with insurer policy and market conditions rather than with medical evidence.

This is a pending-review draft for editorial and clinical fact-checking. It has not yet been confirmed by a licensed reviewer against current Maine payer policy.

The direct answer

Modafinil requires a prescription in every US state, including Maine. There is no Maine-specific rule that makes access easier or harder than in other states; the medication is regulated federally as Schedule IV, and Maine licenses the same prescriber types (MD, DO, NP, PA) that most states license to prescribe it. A patient with a documented diagnosis of narcolepsy, OSA-related sleepiness, or shift-work disorder can typically be evaluated by telehealth and receive an electronic prescription sent to a Maine pharmacy, provided the prescribing clinician holds an active Maine license and a Maine-registered DEA number. Coverage, prior-authorization criteria, and cash price are insurer- and pharmacy-specific and change over time, so they should be confirmed directly rather than assumed from a general guide.

What modafinil is approved for, and what it is not

The FDA-approved indications for modafinil are narcolepsy, OSA with residual excessive sleepiness despite treatment of the underlying apnea, and shift-work disorder. Prescribing for other reasons, such as general fatigue, ADHD, or cognitive enhancement in people without a sleep disorder, is off-label. Off-label use is legal for a clinician to prescribe based on their judgment, but it is not FDA-approved, evidence for benefit outside the labeled indications is limited and inconsistent, and insurers frequently do not cover it. The current FDA prescribing information is the authoritative source for dosing, warnings, and drug interactions: Provigil prescribing information, FDA.

The label describes a standard starting dose of 200 mg once daily, taken in the morning for narcolepsy and OSA or roughly one hour before a shift for shift-work disorder, and notes that modafinil induces the CYP3A4 enzyme, which can reduce the effectiveness of hormonal contraceptives. Anyone using hormonal birth control should discuss alternative or additional contraception with their prescriber before starting modafinil, and this is not a substitute for that conversation.

Who can prescribe modafinil in Maine

A clinician needs an active Maine license and a valid DEA registration to prescribe a Schedule IV drug in the state. That includes physicians (MD/DO), nurse practitioners, and physician assistants practicing under Maine's scope-of-practice rules. Nurse practitioners in many states, including Maine, can obtain independent prescribing authority after an initial period of supervised or collaborative practice; the exact requirements and timelines are set by the Maine Board of Nursing and can change, so a specific number of required months should be confirmed with the board rather than treated as fixed. General background on nurse practitioner scope of practice is available from professional organizations, though state boards are the authoritative source for current rules.

Sleep medicine specialists and neurologists most often manage narcolepsy. Primary care clinicians commonly manage shift-work disorder. If a current provider is not comfortable prescribing a controlled wakefulness-promoting agent, asking for a referral to a sleep medicine clinic is a reasonable next step; Maine has sleep centers affiliated with several of its major health systems.

Can you get a modafinil prescription by telehealth in Maine

Telehealth prescribing of Schedule IV medications, including modafinil, is generally permitted in Maine when a licensed clinician conducts a real-time video evaluation and documents a clinical rationale, consistent with federal telemedicine rules for controlled substances that followed the end of the COVID-era public health emergency flexibilities. Because federal telehealth prescribing rules for controlled substances have been revised more than once in recent years, the current requirement (whether an initial in-person exam is needed for a new patient, and under what conditions it can be waived) should be verified at the time of the visit rather than assumed from this page.

In practice, a telehealth evaluation for modafinil typically includes a sleep history, a validated sleepiness questionnaire such as the Epworth Sleepiness Scale, review of any prior sleep study, and a medication reconciliation. A patient with an established narcolepsy or shift-work disorder diagnosis may receive a prescription at the first visit. A patient with no prior diagnosis who is being evaluated for suspected narcolepsy will usually need a formal sleep study (polysomnography, often followed by a multiple sleep latency test) before a prescription is written, because narcolepsy is a diagnosis that depends on objective testing, not history alone.

If using a national telehealth platform rather than a Maine-based clinic, confirm that the specific prescribing clinician holds a Maine license and a Maine-registered DEA number before the appointment. Some Maine pharmacists prefer or require an in-state DEA number for controlled-substance prescriptions, though this varies by pharmacy.

What workup typically precedes a prescription

Modafinil does not require mandatory baseline lab testing under the FDA label, but many prescribers order a basic metabolic panel and thyroid testing to rule out other causes of fatigue, since hypothyroidism and other medical conditions can mimic excessive daytime sleepiness. Blood pressure should be checked before starting modafinil and periodically afterward, because modafinil is associated with small increases in heart rate and blood pressure in some patients; the exact magnitude reported in the FDA label should be read directly from the label rather than approximated here, since precise figures vary by dose and study population.

For a narcolepsy diagnosis, sleep medicine guidelines call for nocturnal polysomnography followed by a multiple sleep latency test. For shift-work disorder, a documented history of a rotating or night-shift schedule with associated impairing sleepiness is generally sufficient, and a polysomnogram is not routinely required. A clinician's diagnostic approach should follow current American Academy of Sleep Medicine guidance; a reader who wants the specific diagnostic thresholds should ask their sleep specialist to walk through the criteria rather than rely on a number quoted secondhand.

Insurance coverage and prior authorization: what is verifiable and what is not

Generic modafinil is on most commercial and Medicaid formularies in some tier, and prior authorization is common for both branded Provigil and off-label use. Maine's Medicaid program (MaineCare) does require prior authorization for many controlled-substance prescriptions, but the specific documentation requirements, approval timelines, and appeal deadlines are set by MaineCare policy and can change. This page cannot state a reliable turnaround time or list of required diagnosis codes without risking an outdated or wrong answer; a patient or prescriber's office should confirm current MaineCare prior-authorization criteria directly with MaineCare or the patient's specific commercial plan before assuming any timeline.

What is stable: prior authorization for modafinil generally requires a documented diagnosis consistent with an FDA-approved indication, and off-label prescriptions (for cognitive enhancement, general fatigue, or conditions like MS-related fatigue not on the label) are approved far less often and may not be covered at all.

Pharmacy access, compounding, and mail order

Generic modafinil tablets have been available since patent expiration in the early 2010s and are stocked at most large chain and independent pharmacies. Cash price varies by pharmacy, discount card, and date, so any specific dollar figure quoted for Maine should be treated as a snapshot rather than a current price; checking a pharmacy directly or a live price-comparison tool is more reliable than a fixed number in an article.

Maine licenses 503A compounding pharmacies through the Maine Board of Pharmacy. A 503A pharmacy can prepare a patient-specific modafinil formulation (for example, a non-standard dose or an alternative dosage form) under a valid prescription and applicable USP compounding standards. A compounded product is not FDA-approved as a finished drug the way commercially manufactured tablets are; it is regulated as a pharmacy compounding activity, and its use should generally be reserved for a documented clinical need that a commercially available strength cannot meet, such as an inability to take standard tablets.

Schedule IV medications can generally be shipped by mail through USPS or private carriers under DEA rules, and mail-order pharmacy benefit managers commonly serve Maine addresses. Processing times vary by pharmacy and should be confirmed with the specific mail-order service rather than assumed.

Prescriptions can also be transferred between pharmacies, including across state lines, under standard DEA rules for Schedule IV drugs; a Schedule IV prescription can generally be transferred once between pharmacies unless the pharmacies share a real-time electronic database. Someone relocating to Maine should bring the current prescription bottle and prescriber contact information, and be prepared to obtain a new prescription from a Maine-licensed clinician if no refills remain.

Realistic timeline, without overstating precision

For a patient with an existing, documented diagnosis, a telehealth visit can often be scheduled within days, and if no prior authorization is required, the pharmacy may dispense the same day the prescription is sent. For a new patient without a prior diagnosis, the process takes substantially longer, because a sleep study is usually required before a narcolepsy diagnosis can be confirmed, and sleep lab scheduling varies widely by facility and season. This page does not have a Maine-specific, currently verified average wait time for polysomnography or prior authorization, and quoting a precise number of days or weeks here would overstate what is actually known. A patient who wants a realistic estimate should ask the specific sleep clinic and insurer directly.

Off-label use: what the evidence actually supports

Modafinil is sometimes prescribed off-label for conditions such as fatigue associated with multiple sclerosis or, more controversially, as a cognitive enhancer in people without a sleep disorder. Evidence for cognitive enhancement in healthy, non-sleep-deprived adults is limited, with small and inconsistent effects reported across trials; a reader considering this use should understand that it falls outside the FDA-approved indication, is generally not covered by insurance, and has a different, less established risk-benefit profile than treatment of a diagnosed sleep disorder.

Safety monitoring and when to seek urgent care

Modafinil's most commonly reported side effects include headache, nausea, and nervousness. A rare but serious risk associated with modafinil is severe skin reaction, including Stevens-Johnson syndrome; the FDA label instructs patients to stop the medication and seek medical attention immediately at the first sign of rash, blistering, or skin peeling. Anyone who develops a new rash, fever, swollen glands, or facial swelling while taking modafinil should seek urgent evaluation rather than waiting for a routine follow-up. Sustained chest pain, significant new hypertension symptoms, or signs of an allergic reaction (difficulty breathing, swelling of the throat) also warrant emergency care.

Routine follow-up after starting modafinil typically includes a blood pressure recheck within the first month and periodic visits thereafter for stable patients; a telehealth visit is generally appropriate for stable monitoring when no dose change is being considered.

Evidence boundary: what is established, what is plausible, what is not established

Established by FDA labeling and controlled trials: modafinil improves subjective and objective measures of daytime sleepiness in narcolepsy, OSA-related residual sleepiness, and shift-work disorder at the approved 200 mg dose, and it carries a labeled Schedule IV controlled-substance status with known interactions (notably reduced hormonal contraceptive efficacy) and a rare but serious skin-reaction risk.

Plausible but not rigorously established for the general population: meaningful cognitive-enhancement benefit in healthy adults without a sleep disorder, and any specific benefit for conditions like MS-related fatigue beyond the labeled indications.

Not established, and specific to this page: any fixed Maine-specific timeline, price, or MaineCare prior-authorization turnaround. Those facts exist and change in the real world, but this article does not have a verified, current source for exact numbers, and presenting invented figures would be worse than acknowledging the gap.

Verification checklist: stable facts vs. facts that change

Use this checklist to distinguish between information about modafinil that represents established clinical knowledge and details that require verification at your appointment, since they may reflect current treatment guidelines, cost considerations, or your particular insurance coverage.

Stable (federal regulation and clinical evidence, unlikely to change quickly)

• Modafinil is FDA-approved for narcolepsy, OSA-related residual sleepiness, and shift-work disorder.
• Modafinil is a Schedule IV controlled substance under federal law.
• The FDA label lists rash/Stevens-Johnson syndrome as a reason to stop the drug immediately and seek care.
• Modafinil induces CYP3A4 and can reduce hormonal contraceptive effectiveness.
• A narcolepsy diagnosis generally requires objective sleep testing (polysomnography plus multiple sleep latency testing), not history alone.

Date-sensitive, confirm before relying on it

• Whether a specific telehealth platform's clinicians hold an active Maine license and Maine DEA registration today.
• Current federal and Maine rules on whether an in-person exam is required before an initial controlled-substance telehealth prescription.
• MaineCare's current prior-authorization form, required diagnosis codes, and turnaround time.
• Your specific commercial insurer's formulary tier and prior-authorization criteria for modafinil.
• Cash price at a specific Maine pharmacy on a given day, and any discount card terms.
• Which Maine 503A compounding pharmacies currently compound modafinil and their current turnaround time.
• Mail-order pharmacy shipping timelines for a new versus refill prescription.

How to verify

• Call the prescriber's office and ask them to confirm licensure and DEA registration state.
• Call MaineCare member services or your commercial insurer's pharmacy benefits line directly rather than relying on a general article.
• Call the dispensing pharmacy the same week you plan to fill the prescription.

Questions patients actually ask